Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 94 for your search:
Drug:  leuprolide acetate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TRE1001, NCT01161563

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A-97-52014-181, 2011-004213-16, NCT01673984

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor:
Protocol IDs: SCTN-BR9401, EU-94002, UKCCCR-ABC/BR9401, NCT00002580

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor:
Protocol IDs: NCRI-ABC, CRC-TU-BR3010, SCTN-BR9401/BR9402, YRCO-ABC, EU-94029, UKCCCR-ABC, NCT00002582

5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: premenopausal
Sponsor: NCI
Protocol IDs: E-3193, CLB-9494, NCCTG-933252, SWOG-9347, INT-0142, E3193

6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: RTOG-9408, CDR0000063821, NCT00002597

7.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: SWOG-S9615, SWOG-9615, S9615

8.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-8892, CLB-E8892, SWOG-E8892, NCT00002881, E8892

9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: RTOG-9608, RTOG-96-08

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: ID97-077, P30CA016672, MDA-ID-97077, E-97077, NCI-T97-0069, CDR0000066733, NCI-2009-00818, T97-0069, NCT00003645

11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 000080, 00-C-0080, NCI-00-C-0080, NCI-T99-0053, T99-0053, NCT00020085, NCT00004635

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor:
Protocol IDs: AGOSG-OVAR-2.1

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8494, MAOP-4384, NCCTG-INT-0036, NCOG-4P842J, NPCTG-2200, INT-0036

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: premenopausal
Sponsor:
Protocol IDs: MSHMC-1609, NCI-V87-0248

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 84
Sponsor:
Protocol IDs: MSHMC-1642, NCI-V87-0249

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 40 to 85
Sponsor:
Protocol IDs: FCCC-86814, NCI-V87-0282

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 20 to 80
Sponsor:
Protocol IDs: MDA-DM-88027, NCI-V88-0440

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: MSKCC-92050, NCI-V92-0124

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MRC-PROST, EU-90038

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 80
Sponsor: Other
Protocol IDs: CDR0000270970, FRE-FNCLCC-GETUG-12/0203, EU-20238, NCT00055731

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000353209, U10CA031946, CALGB-90202, CAN-NCIC-PRC2, ECOG-CALGB-90202, SWOG-CALGB-90202, NCT00079001

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 40 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OL-007, NCT00076531

23.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CRO-04-62, NCT00128531

24.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: TROG 03.04, ACTRN12607000097448, NCT00193856

25.

Phase: Phase III
Type: Treatment
Status: Completed
Age: No age specified
Sponsor: Other
Protocol IDs: 05-8-4, NCT00243646
1     
New Search